A growing number of clinicians rely on AdaptDx to detect age-related macular degeneration in their adult patients. Our customers tell the story of how they’re fighting against blindness caused by AMD.
The MacuLogix team gives the most superior installation, education, and support of any ophthalmologic instrument that I can think of. By discussing and identifying your personal practice flow, recommendations and support will be given to best start making this a reflex to discuss with patients and perform in your office on a daily basis.
The marketing package MacuLogix provides to their customers is the best I have seen with any equipment company!
Starting therapy early may have huge benefits when we project forward another 10 or 20 years. I believe this device is helping me save vision for many people.
AdaptDx may find macular degeneration at least three years before you actually see any clinical signs. Do you want to wait to diagnose glaucoma until someone has a vision-threatening visual field loss? No, you don’t. And we should be thinking the same way about AMD. Let’s find it in its earliest stage so that we can do something about it and try to prevent the bad outcomes.
Since incorporating AdaptDx in our office we can tell patients that even though they have a family history or are concerned about the disease, we have a device that can help detect it before it is too late. Diagnosing AMD at the subclinical level gives us a plan of action for treatment. Having this plan brings comfort to not only myself but the patients so they can walk out my practice doors with a newfound confidence in their future.